Application of CRISPR for In Vivo Mouse Cancer Studies

Martin K Thomsen1,2

  • 1Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.

Cancers
|October 27, 2022
PubMed

Insights

Clustered regularly interspaced short palindromic repeats (CRISPR) technology enables precise gene editing in vivo for cancer research. This review explores CRISPR applications in generating complex cancer models and analyzing their unique characteristics.

Area of Science:

  • Genomics and Molecular Biology
  • Cancer Research
  • Biotechnology

Background:

  • Clustered regularly interspaced short palindromic repeats (CRISPR) technology is a powerful tool for gene editing in biological research.
  • Its application in cancer research facilitates the study of gene function through loss- or gain-of-function mutations.
  • CRISPR has significantly accelerated the creation of both in vitro and in vivo experimental models.

Purpose of the Study:

  • To review the use of CRISPR for generating in vivo cancer models by editing somatic cells in specific organs.
  • To discuss methods for delivering CRISPR/Cas systems to target tissues and cellular compartments.
  • To explore the analysis of complex mutation profiles and the unique biology of CRISPR-induced tumors.

Main Methods:

  • Focus on CRISPR/Cas delivery methods for in vivo gene editing in designated tissues.
  • Discussion of simultaneous multi-gene targeting for complex mutation generation.
  • Exploration of analytical techniques for complex genomic data and clonal evolution in CRISPR-induced tumors.

Main Results:

  • CRISPR enables efficient generation of in vivo cancer models with specific mutations.
  • Simultaneous targeting of multiple genes allows for the creation of complex genetic landscapes.
  • CRISPR-induced tumors exhibit distinct characteristics, including clonal evolution, offering novel insights into cancer biology.

Conclusions:

  • CRISPR technology is revolutionizing the creation and study of in vivo cancer models.
  • Future perspectives include in vivo screening, CRISPR activation/inhibition, and advanced prime/base editing techniques.
  • CRISPR holds significant promise for advancing preclinical cancer research and therapeutic development.